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We enjoyed reading the editorial by Kritsotakis
and Gikas [1] concerning surveillance of antibiotic
use. With respect to the best indicator of antibiotic
use, the authors stated that ‘the debate as to the
most appropriate choice of denominator is ongo-
ing’. We would like to make a contribution to this
particular point.
The commonly employed denominators are
mathematically related to each other. Thus, the
value of patient-days (PD) is approximately equal
(@) to admissions (A) · the mean length of stay
(mls), while bed-days (BD) are equal to PD ⁄ occu-
pancy rate (Or), and BD @A · mls ⁄Or. These
relationships are transferred to the indicators
themselves, so that defined daily doses
(DDDs) ⁄A ⁄DDs ⁄PD @mls, DDDs ⁄BD ⁄DDDs ⁄
PD = Or, and DDDs ⁄BD ⁄DDDs ⁄A @Or ⁄mls.
Considering that the denominators can usually
be obtained easily from the records of most
institutions, all three indicators could be shown
on the same graph. An absence of synchronicity in
the slopes of the different lines would reflect
changes in mls, Or, or both, thereby revealing
changes in the risk composition of the system
being studied at different time-points, which, in
turn, may warrant further investigation.
For example, the same value of PD at two time-
points could be obtained by a large number of
admissions with a short length of stay, or by a
small number of admissions with a long length of
stay. If only DDDs ⁄PD is shown, the difference
will not be evident, but if this indicator is shown
together with DDDs ⁄A, the difference is revealed.
Fig. 1 shows an example of two time-points
(August 2004 and October 2004) with equal
DDDs ⁄PD values for piperacillin–tazobactam.
However, the line corresponding to DDDs ⁄A is
not synchronous with the line representing
DDDs ⁄PD at the August 2004 time-point, indica-
ting that there were a larger number of admis-
sions and a shorter mean length of stay compared
with the October 2004 timepoint. This reflects
differences in risks at the two time-points. There-
fore, we suggest that the use of the three indica-
tors, especially when depicted on a graph, may be
a more useful approach than the use of single
denominators.
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Fig. 1. Example of piperacillin–tazobactam consumption
measured in terms of defined daily doses per admissions
(DDDs ⁄A) and defined daily doses per patient-days
(DDDs ⁄PD), shown in comparison with mean length of
stay (mls).
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